S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
S&P 500   3,811.15 (-0.48%)
DOW   30,932.37 (-1.50%)
QQQ   314.14 (+0.42%)
AAPL   121.26 (+0.22%)
MSFT   232.38 (+1.48%)
FB   257.62 (+1.15%)
GOOGL   2,021.91 (+0.30%)
AMZN   3,092.93 (+1.17%)
TSLA   675.50 (-0.99%)
NVDA   548.58 (+3.06%)
BABA   237.76 (-1.01%)
CGC   32.75 (-1.39%)
GE   12.54 (-1.72%)
MU   91.53 (+3.87%)
NIO   45.78 (-2.20%)
AMD   84.51 (+2.54%)
T   27.89 (-2.58%)
F   11.70 (-0.51%)
ACB   10.52 (-2.77%)
DIS   189.04 (-1.02%)
BA   212.01 (-2.05%)
NFLX   538.85 (-1.44%)
BAC   34.71 (-3.40%)
Log in
NASDAQ:MGEN

Miragen Therapeutics Short Interest Ratio and Short Volume

$16.44
-0.54 (-3.18 %)
(As of 02/26/2021 12:00 AM ET)
Add
Compare
Today's Range
$16.12
Now: $16.44
$17.15
50-Day Range
$16.51
MA: $20.20
$24.93
52-Week Range
$4.66
Now: $16.44
$34.05
Volume31,312 shs
Average Volume134,027 shs
Market Capitalization$64.25 million
P/E RatioN/A
Dividend YieldN/A
Beta1.66

Short Interest

Miragen Therapeutics (NASDAQ:MGEN) Short Interest Data

Current Short Volume161,700 shares
Previous Short Volume188,500 shares
Change Vs. Previous Month:-14.22%
Dollar Volume Sold Short$3.55 million
Short Interest Ratio / Days to Cover0.0
Last Record DateDecember, 31 2020
Outstanding Shares30,930,000 shares
Float Size3,690,000 shares
Short Percent of Float4.38%
Today's Trading Volume31,312 shares
Average Trading Volume134,027 shares
Today's Volume Vs. Average-76.64%

Short Interest Over Time


Miragen Therapeutics (NASDAQ:MGEN) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
12/31/2020161,700 shares $3.55 million -14.2%4.4%0.4 $21.93
12/15/2020161,700 shares $2.70 million -14.2%4.4%0.4 $16.69
11/30/2020188,500 shares $3.76 million +23.9%5.1%0.4 $19.95
11/15/2020152,100 shares $2.68 million -97.6%N/A0.3 $17.64
10/30/20206,200,000 shares $97.84 million +321.8%N/A1.1 $15.78
10/15/20201,470,000 shares $764,400.00 -6.4%N/A1.3 $0.52
9/30/20201,570,000 shares $894,900.00 -10.3%N/A0.7 $0.57
9/15/20201,750,000 shares $1.42 million -1.7%N/A0.8 $0.81
8/31/20201,780,000 shares $1.64 million -7.3%N/A0.6 $0.92
8/14/20201,920,000 shares $1.67 million -5.0%N/A0.6 $0.87
7/31/20202,020,000 shares $2.20 million +61.6%N/A0.7 $1.09
7/15/20201,250,000 shares $1.39 million +6.8%N/A0.4 $1.11
6/30/20201,170,000 shares $1.45 million +138.4%N/A0.7 $1.24
6/15/2020490,800 shares $534,972.00 +52.5%N/A0.3 $1.09
5/29/2020321,900 shares $370,185.00 -6.8%N/A0.3 $1.15
5/15/2020345,300 shares $341,847.00 +5.4%N/A0.4 $0.99
4/30/2020327,600 shares $278,460.00 +60.2%N/A0.3 $0.85
4/15/2020204,500 shares $134,970.00 -0.9%N/A0.1 $0.66
3/31/2020206,300 shares $119,654.00 -29.5%N/A0.1 $0.58
3/13/2020292,600 shares $134,596.00 -35.2%1.0%0.2 $0.46
2/28/2020451,200 shares $189,504.00 +146.7%1.6%0.2 $0.42
2/14/2020182,900 shares $122,543.00 -82.4%0.7%0.1 $0.67
1/31/20201,040,000 shares $800,800.00 +132.5%4.0%0.5 $0.77
1/15/2020447,400 shares $371,342.00 -22.0%1.7%0.4 $0.83
12/31/2019573,800 shares $556,586.00 -10.8%2.2%1.2 $0.97

Miragen Therapeutics (NASDAQ:MGEN) Short Interest FAQ

speech bubbles
speech bubbles











What is Miragen Therapeutics' current short interest?

Short interest is the volume of Miragen Therapeutics shares that have been sold short but have not yet been closed out or covered. As of December 31st, investors have sold 161,700 shares of MGEN short. 4.38% of Miragen Therapeutics' shares are currently sold short. View details.

What is a good short interest percentage for Miragen Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.38% of Miragen Therapeutics' floating shares are currently sold short.

Is Miragen Therapeutics' short interest increasing or decreasing?

Miragen Therapeutics saw a decline in short interest during the month of December. As of December 31st, there was short interest totaling 161,700 shares, a decline of 14.2% from the previous total of 188,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Miragen Therapeutics' float size?

Miragen Therapeutics currently has issued a total of 3,908,000 shares. Some of Miragen Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Miragen Therapeutics currently has a public float of 3,690,000 shares.

How does Miragen Therapeutics' short interest compare to its competitors?

4.38% of Miragen Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "medical laboratories" compare to Miragen Therapeutics: Laboratory Co. of America Holdings (1.82%), Quest Diagnostics Incorporated (1.90%), Guardant Health, Inc. (3.84%), Natera, Inc. (0.00%), Invitae Co. (0.00%), Elekta AB (publ) (0.00%), CareDx, Inc (0.00%), Veracyte, Inc. (0.00%), Fulgent Genetics, Inc. (23.08%), and Castle Biosciences, Inc. (7.91%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($5.18 billion), ViacomCBS Inc. ($4.71 billion), Analog Devices, Inc. ($4.45 billion), Aon Plc ($4.28 billion), Snap Inc. ($3.70 billion), Moderna, Inc. ($3.00 billion), The Clorox Company ($2.46 billion), Peloton Interactive, Inc. ($2.40 billion), The Kroger Co. ($2.38 billion), and Expedia Group, Inc. ($2.37 billion). View all of the most shorted stocks.

What does it mean to sell short Miragen Therapeutics stock?

Short selling MGEN is an investing strategy that aims to generate trading profit from Miragen Therapeutics as its price is falling. Miragen Therapeutics' stock is trading down $0.54 today. To short Miragen Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Miragen Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Miragen Therapeutics?

A short squeeze for Miragen Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of MGEN, which in turn drives the price of the stock up even further.

How often is Miragen Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including MGEN, twice per month. The most recent reporting period available is December, 31 2020.



This page was last updated on 2/26/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.